Product Information
CEFDINIR 250 MG/5 ML SUSP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1210 per ML under NDC 65862021901. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
250 mg/5mL
Manufacturer
Aurobindo Pharma LimitedNDC
65862021901
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEFDINIRApproval Type
Generic (ANDA)
FDA Application
ANDA065473On Market Since
12/14/2007
Pharmacological Classes
Price Statistics
The NADAC for CEFDINIR 250 MG/5 ML SUSP has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 82.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1210 per ML |
|---|---|
| All-time high | $0.7452 (Jul 16, 2014) |
| All-time low | $0.1127 (Nov 20, 2024) |
| 52-week high | $0.1403 |
| 52-week low | $0.1159 |
| Median price | $0.1737 |
| Average price | $0.2672 |
| Largest weekly change | +47.5% (Mar 22, 2023) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFDINIR 250 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFDINIR 250 MG/5 ML SUSP, manufactured by Aurobindo Pharma Limited, is $0.1210 per ML (NDC 65862021901), effective Jun 24, 2026.
How has the price of CEFDINIR 250 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFDINIR 250 MG/5 ML SUSP has declined 82.5%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFDINIR 250 MG/5 ML SUSP?
Since Nov 28, 2013, the NADAC for CEFDINIR 250 MG/5 ML SUSP has ranged from a low of $0.1127 (Nov 20, 2024) to a high of $0.7452 (Jul 16, 2014), with a median of $0.1737 per ML.
Are there cheaper alternatives to CEFDINIR 250 MG/5 ML SUSP?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CEFDINIR 250 MG/5 ML SUSP, but none are currently priced below it.
Who manufactures CEFDINIR 250 MG/5 ML SUSP?
CEFDINIR 250 MG/5 ML SUSP (NDC 65862021901) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification